News
Videos
Conferences
Events
Resources
Subscribe

|Articles|April 22, 2015

Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer

Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.

Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis

December 19th 2025

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

IL-18-armored CAR T Drives Remissions in Relapsed B-Cell Leukemia

ByDr. Matthew P. Connor

December 19th 2025

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

Patients With Lung Cancer Face Smoking-Related Stigma

ByPatricia I. Moreno

December 19th 2025

Dan, a pancreatic cancer survivor

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

BySpencer Feldman

December 18th 2025

Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.

A Patient’s Journey Through Remission and Mental Health With Non-Hodgkin Lymphoma

December 17th 2025

Trending on CURE

Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis

Key Blood Cancer Advances for Patients From the 2025 ASH Annual Meeting

How Modern Research Is Transforming Metastatic HER2+ Breast Cancer Care

What No One Tells You About Life After Breast Cancer: Fighting for Care

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis